Skip to main content
Clinical Trials/CTRI/2017/08/009254
CTRI/2017/08/009254Recruiting未知

Quantification of levels of biotin and copper in serum and hair samples of women with chronic telogen effluvium

Indian Association of Dermatologists Venereologists and Leprologists0 sites172 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Recruiting
Enrollment
172

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • Consecutive consenting women aged 18-45 years presenting to the dermatology OPD with diffuse hair loss lasting for more than 6 months diagnosed as chronic telogen effluvium based on modified hair wash test and trichoscopy
  • Consenting women with no hair loss attending the dermatology OPD

Exclusion Criteria

  • Cases and Controls:
  • Lactating women
  • Post-menopausal women
  • Prescription drugs known to affect the hair growth within the last six months
  • Known systemic causes of hair loss (symptomatic anemia with Hb < 10gm/dl, overt hypo or hyperthyroidism on treatment, known diabetics and hypertensives on treatment, hepatic and renal diseases, connective tissue diseases, malignancies, tuberculosis)
  • Chronic drug intake
  • Inflammatory dermatoses involving scalp and hair â?? psoriasis, lichen planus, discoid lupus erythematosus
  • History of hair dye application and cosmetic hair treatments like straightening, ironing, perming in the last 6 months.

Investigators

Similar Trials